Baselake reports 9.7% stake in Synlogic
Synlogic, Inc. received a Schedule 13G reporting that investment entities affiliated with Baselake Partners, LP, including Baselake Management, LLC and individual investor David Paolella, beneficially own 1,140,000 shares of Synlogic common stock.
Rhea-AI Filing Summary
Synlogic, Inc. received a Schedule 13G reporting that investment entities affiliated with Baselake Partners, LP, including Baselake Management, LLC and individual investor David Paolella, beneficially own 1,140,000 shares of Synlogic common stock. This represents 9.7% of the outstanding common stock, based on the issuer’s report that 11,698,919 shares were outstanding as of November 6, 2025.
The shares are held by Baselake Partners, LP, with Baselake Management, LLC as investment manager and Paolella as managing member, and they report shared voting and dispositive power over all 1,140,000 shares and no sole voting or dispositive power. The filing states that the securities were not acquired and are not held for the purpose of changing or influencing control of Synlogic.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Synlogic, Inc. (SYBX) does Baselake Partners report on this Schedule 13G?
Who are the reporting persons on the Synlogic (SYBX) Schedule 13G?
What ownership percentage basis is used in the Baselake Schedule 13G for Synlogic (SYBX)?
Does the Baselake Schedule 13G state an intent to influence control of Synlogic (SYBX)?
What class of Synlogic (SYBX) securities is covered by this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.